Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Alector (ALEC - Free Report) is a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 229.4% downward over the last 60 days.
Amyris is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. The Zacks Consensus Estimate for its current year earnings has been revised 135.5% downward over the last 60 days.
BioLife Solutions (BLFS - Free Report) is a next-generation preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. The Zacks Consensus Estimate for its current year earnings has been revised almost 110.3 % downward over the last 60 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Alector (ALEC - Free Report) is a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 229.4% downward over the last 60 days.
Amyris is an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories. The Zacks Consensus Estimate for its current year earnings has been revised 135.5% downward over the last 60 days.
BioLife Solutions (BLFS - Free Report) is a next-generation preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. The Zacks Consensus Estimate for its current year earnings has been revised almost 110.3 % downward over the last 60 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BLFS - FREE
Get the latest research report on ALEC - FREE